Package Insert: Information for the User
CORTISON CHEMICETINA 5 mg/g + 10 mg/g Ointment
Hydrocortisone acetate/ Chloramphenicol
Read this package insert carefully before starting to use this medication, as it contains important information for you.
Contains as active principles hydrocortisone acetate, an anti-inflammatory (a corticosteroid) and chloramphenicol, a broad-spectrum antibiotic, for use on the skin.
Cortison Chemicetina is indicated for:
Local treatment of skin conditions (dermatoses) that respond to corticosteroids with superficial infections caused by germs sensitive to chloramphenicol.
Do not use Cortison Chemicetina:
Warnings and precautions
Consult your doctor or pharmacist before starting to use Cortison Chemicetina.
Children and adolescents
In children under 2 years, this medication is contraindicated, and in children between 2 and 12 years, administration should be limited to short periods of time and the minimum effective amount of the product, as in them it is more likely that the corticosteroid will pass through the skin and cause adverse effects in other areas of the body, such as growth delay, obesity, etc. (see section 4).
Use of Cortison Chemicetina with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
No interactions of Cortison Chemicetina with other medications are known.
Do not apply it with other preparations in the same area.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor before using this medication.
As a general rule, during the first trimester of pregnancy, this medication should not be applied.
This medication will not be used during pregnancy unless your doctor considers that the potential benefit of its use justifies the potential risk to the fetus.
Do not use Cortison Chemicetina on large areas of the skin, for prolonged periods, or with occlusive dressings.
This medication will not be used during breastfeeding unless your doctor considers that the potential benefit of its use justifies the potential risk to the fetus.
Do not apply the medication to the breasts; do not put the child in contact with treated areas.
Driving and operating machinery
This medication does not affect your ability to drive or operate machinery.
Cortison Chemicetina contains lanolin
This medication may cause local skin reactions (such as contact dermatitis) because it contains lanolin.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Cutaneous use.
Generally, apply the ointment 2 to 4 times a day to the affected area over the first 4 days, on clean skin, spreading it smoothly, and then reduce the applications to 1-2 times a day.
The treatment duration is generally not more than 7-10 days.
Use in children and adolescents
If used in children between 2 and 12 years, under medical indication, administration should be done during short periods of time and with the minimum amount of medication possible.
If you use more Cortison Chemicetina than you should
Due to the characteristics and mode of application of this preparation, acute intoxication phenomena are not expected after a single cutaneous application of an overdose (application to a large area, under favorable conditions for absorption).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicological Information Service, Telephone 91 562 04 20 (indicating the medication and the amount ingested).
If you forgot to use Cortison Chemicetina
Do not use a double dose to compensate for the missed doses and continue with your regular schedule according to the instructions indicated by your doctor or those described in this prospectus.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can produce adverse effects, although not all people may experience them.
Due to the presence of chloramphenicol, in very rare cases, serious blood disorders (dyscrasias) such as aplastic or hypoplastic anemia, thrombocytopenia, and granulocytopenia may occur; they are normally reversible and are much more frequent with high doses and in other routes of administration.
Other effects include: Allergic reaction to one of the components, with symptoms on the skin and others of greater importance.
The following adverse effects have been reported with the use of corticosteroids administered locally, especially with prolonged application, in extensive areas, with dressings or occlusive materials, and/or in children:
Unknown frequency (cannot be estimated from available data):
Adverse effects may occur not only in the area treated with the corticosteroid, but also in completely different areas of the body, which occurs if the active principle passes through the skin. This, for example, may increase eye pressure (glaucoma) or could produce a condition characterized by a rounded face, weight gain, hump, delayed healing, etc. (Cushing's syndrome); delayed growth in children, increased blood pressure, cataracts.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Do not store at a temperature above 30º C. Store in the original packaging.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Cortison Chemicetina
Appearance of the product and content of the packaging
Cortison Chemicetina is a greasy ointment with a soft consistency, white or slightly yellowish in color.
It is presented in a 5 g tube.
CORTISON CHEMICETINA 25 mg/g + 20 mg/g ointment
Holder of the marketing authorization and responsible for manufacturing
Teofarma S.r.l.
Via F.lli Cervi 8
27010 VALLE SALIMBENE (Pavia)
ITALY
Last review date of this leaflet:04/ 2015.
The detailed and updated information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.